Myocardial regulatory proteins and heart failure.
Cardiac troponin T (cTnT) and cardiac troponin I (cTnI) are considered to be the most specific and sensitive biochemical markers of myocardial damage. Troponins have been studied in a wide range of clinical settings, including heart failure; however, there are few data on the role of regulatory proteins in the pathogenesis of heart failure, although a few interesting hypotheses have been proposed. A considerable body of evidence favours the view that alteration of the myocardial thin filament is the primary event leading to defective contractility of the failing myocardium, while the changes in Ca(2+) handling are a compensatory response. A better understanding of the role of regulatory proteins under different physiological and pathological conditions could lead to new therapeutic approaches in heart failure. Recently, calcium sensitisation has been proposed as a novel method by which cardiac performance may be enhanced via an increase in the affinity of troponin C for calcium but without affecting intracellular calcium concentration. To date, the only calcium sensitizer used in clinical practice is levosimendan.
Adamcová
Michaela
M
Department of Physiology, Faculty of Medicine in Hradec Králové, Charles University in Prague, Simkova 870, 500 38 Hradec Králové, Czech Republic. adamcova@ifhk.cuni.cz
Stĕrba
Martin
M
Simůnek
Tomás
T
Potácová
Anna
A
Popelová
Olga
O
Gersl
Vladimír
V
D002303:Cardiac Output, Low / Q000503:physiopathology*; D006801:Humans; D019210:Troponin I / Q000502:physiology*; D020107:Troponin T / Q000502:physiology*
D019210:Troponin I; D020107:Troponin T